(Adnkronos) - “Oggi, gli studi sulla disponibilità di vaccini e sulla modalità di immunizzazione verso il virus respiratorio sinciziale (Rsv) ci fanno tornare sull’opportunità di ridurre complessivamente l'impatto di queste patologie e di rafforzare il valore delle vaccinazioni”. Lo ha detto Fabrizio Ernesto Pregliasco, direttore della Scuola di specializzazione in Igiene e Medicina preventiva dell’università degli studi di Milano e direttore sanitario dell’Azienda Irccs ospedale Galeazzi Sant’Ambrogio di Milano, in occasione della conferenza stampa, organizzata a Roma da Gsk sul virus respiratorio sinciziale.
Category
🗞
NewsTranscript
00:00The main protagonist in the past was the influence, the Covid has overcome the influential virus to the right,
00:11but in reality, with studies already of the past, but today more in-depth,
00:16it is seen how there are other co-protagonists, who are those who make the difference from year to year,
00:22compared to the number of cases that determine.
00:25The syncytial respiratory virus was known for the heavy, bad effects that determine the younger children,
00:32this bronchiolitis, which is a disease that rightly scares parents,
00:37and which has really heavy effects for them, of hospitalization and intensive care.
00:43But in reality, then, in the adult, in the elderly, it overlaps in the symptomatology,
00:50indeed, some investigations say with an even higher effect and heaviness of the symptomatology compared to the influence,
00:59and that, how to say, until the past it did not have this relevance.
01:05Today, studies also of availability of vaccines, of immunization modalities towards this virus,
01:12make us return to the topic and be able to give the opportunity to reduce the overall impact of these pathologies,
01:21and indeed, to strengthen the value of vaccination.
01:25The anti-influential vaccine, often in the elderly, was seen with little satisfaction,
01:31because the elderly vaccinated himself and then said, I still suffered the influence.
01:36The anti-influential vaccine, like all vaccines, does not have a 100% effectiveness,
01:40but above all, the subject may not have had the influence for which the vaccine did not work.
01:48Complementing with modalities that will be implemented in the next vaccination plans,
01:53of these vaccinations, will reduce the impact of these respiratory infections,
01:59the hospitalizations, the excesses, the improper use of antibiotics for these pathologies, which are all viral.